User:Mr. Ibrahem/Pitavastatin
Clinical data | |
---|---|
Trade names | Livalo, Livazo, Zypitamag, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a610018 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth (tablets) |
Drug class | Statin[1] |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 60% |
Protein binding | 96% |
Metabolism | Liver (CYP2C9, minimally) |
Elimination half-life | 11 hours |
Excretion | Faeces |
Identifiers | |
| |
Chemical and physical data | |
Formula | C25H24FNO4 |
Molar mass | 421.461 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pitavastatin, sold under the brand name Livalo among others is a medication used to treat abnormal lipid levels and reduce the risk of heart disease.[1] It is taken by mouth.[1]
Common side effects include muscle pain and diarrhea.[1] Other side effects may include muscle breakdown with kidney problems, liver problems, diabetes, allergic reactions, and memory problems.[1] Use in pregnancy may harm the baby.[1] It is a statin and works by blocking HMG-CoA reductase.[1]
Pitavastatin was patented in 1987 and approved for medical use in 2003.[2] It was approved in the United States in 2009.[1] It is available in a number of countries in Europe.[3] In the United States 3 month of medication costs about 1,000 USD as of 2021.[4]
References[edit]
- ^ a b c d e f g h i j k "Pitavastatin Monograph for Professionals". Drugs.com. Archived from the original on 24 January 2021. Retrieved 28 October 2021.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 473. ISBN 9783527607495. Archived from the original on 16 May 2021. Retrieved 18 October 2021.
- ^ "List of nationally authorised medicinal products" (PDF). Archived (PDF) from the original on 28 October 2021. Retrieved 28 October 2021.
- ^ "Livalo Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 10 May 2016. Retrieved 28 October 2021.